000			03048nam a2200133Ia 4500
008			220615s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aClinical Studies, Big Data, and Artificial Intelligence in Nephrology and Transplantation
546			_aEnglish[eng]
650			_atacrolimus||C/D ratio||tacrolimus metabolism||everolimus||conversion||kidney transplantation||gut microbiome||renal transplant recipient||diarrhea||immunosuppressive medication||gut microbiota||16S rRNA sequencing||butyrate-producing bacteria||Proteobacteria||torquetenovirus||immunosuppression||transplantation||immunosuppressed host||outcome||renal transplantation||Goodpasture syndrome||anti-GBM disease||epidemiology||hospitalization||outcomes||acute kidney injury||risk prediction||artificial intelligence||patent ductus arteriosus||conservative management||blood pressure||eradication||interferon-free regimen||hepatitis C infection||kidney transplant||allograft steatosis||lipopeliosis||transplant numbers||live donors||public awareness||Google TrendsTM||machine learning||big data||nephrology||chronic kidney disease||NLR||PLR||RPGN||predictive value||hemodialysis||withdrawal||cellular crescent||global sclerosis||procurement kidney biopsy||glomerulosclerosis||minimally-invasive donor nephrectomy||robot-assisted surgery||laparoscopic surgery||organ donation||living kidney donation||MeltDose®||LCPT||renal function||liver transplantation||metabolism||erythropoietin||fibroblast growth factor 23||death||weekend effect||in-hospital mortality||comorbidity||dialysis||elderly||klotho||α-Klotho||FGF-23||kidney donor||Nephrology||CKD-MBD||CKD-Mineral and Bone Disorder||deceased donor||Eurotransplant Senior Program||risk stratification||intensive care||kidney transplant recipients||long-term outcomes||graft failure||cardiovascular mortality||lifestyle||inflammation||vascular calcification||bone mineral density||dual-energy X-ray absorptiometry||living donation||repeated kidney transplantation||graft survival||prolonged ischaemic time||patient survival||pre-emptive transplantation||metabolomics||urine||acute rejection||allograft||cystatin C||hyperfiltration||kidney injury molecule (KIM)-1||tubular damage||genetic polymorphisms||(cardiac) surgery||inflammatory cytokines||clinical studies||chronic kidney disease (CKD)||no known kidney disease (NKD)||ICD-10 billing codes||phenotyping||electronic health record (EHR)||estimated glomerular filtration rate (eGFR)||machine learning (ML)||generalized linear model network (GLMnet)||random forest (RF)||artificial neural network (ANN), clinical natural language processing (clinical NLP)||discharge summaries||laboratory values||area under the receiver operating characteristic (AUROC)||area under the precision-recall curve (AUCPR)||fibrosis||extracellular matrix||collagen type VI||living-donor kidney transplantation||ethnic disparity
700			_aCheungpasitporn, Wisit||Thongprayoon, Charat||Kaewput, Wisit
856			_uhttps://mdpi.com/books/pdfview/book/3882
942			_cEB
999			_c11875 _d11875